Skip to main content
PRIMR23 SBER23 Main banner
Icon Legend
Presentation Icons
Pre-Reg Required
Pre-Reg Required
Additional Fee
Additional Fee
Livestreaming Session Icon
Livestreaming Session Icon
Live Session Recorded
Live Session Recorded
On-Demand Session
On-Demand Session
CIP Accredited
CIP Accredited
CPIA Accredited
CPIA Accredited
Call for Session Proposal
Call for Session Proposal
Human Subjects Research
Human Subjects Research
IACUC/Animal Care and Use
IACUC/Animal Care and Use
Crossover
Crossover
Institutional Leadership
Institutional Leadership
Workshop Series
Workshop Series
Thought Leader Series
Thought Leader Series
Deep Dive Series
Deep Dive Series
Learning Lab Series
Learning Lab Series
Networking Series
Networking Series
Vendor Insight Series
Vendor Insight Series
Pillars of PRIM&R Poster Award
Pillars of PRIM&R Poster Award
Poster Icons
Record Session Icon
Record Session Icon
Pre-Reg Required
Pre-Reg Required
Part I/II
Part I/II
CSP Icon
CSP Icon
Livestreaming Session Icon
Livestreaming Session Icon
Prerecorded Session Icon
Prerecorded Session Icon
CIP Accredited
CIP Accredited
Pillars Icon
Pillars Icon
Back
View Video

2023 PRIM&R Annual Conference

Shared Research Oversight Challenges

IACUC Protocol Review

FDA Regulated Research

[IN-PERSON/LIVESTREAMED] Plenary Session: The Lifespan of a Research Protocol: The Journey From Research Using Nonhuman Animals to Research Involving Humans

Tuesday, December 5, 2023
2:30 PM – 3:45 PM ET
Location: Ballroom AB
Thought Leader Series Call for Session Proposal Crossover Livestreaming Session Icon
This plenary session will be held in-person, livestreamed for the Virtual Meeting, and recorded for on-demand access by attendees registered for PRIMR23 on this day.

Research may move from the laboratory to human subjects or from nonhuman animal models to human subjects. Animal-to-human research/clinical trials is neither a one-way street nor is it a straight line/sequential; there might be many back and forths. What clinicians see in practice may end up back in the nonhuman animal research realm to better understand underlying mechanisms so as to develop preventions and cures. Is the information from nonhuman animal research limited in time in its applicability? Are there reasons to revisit research in nonhuman animals at different stages when it is used in humans or triggered by certain events. Is the characterization of an adverse event different for the two species? Should it be? And, how do we define the relevance of adverse events in animals to adverse events in humans? 

Learning Objectives:

  • Review how research in nonhuman animals informs further research on the same agent in humans
  • Consider how adverse events in nonhuman animals translates specifically to adverse events in humans
  • Learn how to identify when previous research on nonhuman animals may need to be revisited in light of events occurring as the research in humans progresses